Ibuprofen, 2-(4-isobutylphenyl)propionic acid, belongs to the class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs) and was discovered by Dr. Stewart Adams in 1961. It was first marketed in 1969 in the United Kingdom and 1974 in the United States. Ibuprofen is prescribed commonly as an analgesic, antipyretic and anti-inflammatory agent in conditions like osteoarthritis, rheumatoid arthritis, juvenile idiopathic arthritis, and acutely painful musculoskeletal conditions. Off-label uses include for conditions like cystic fibrosis to slow progression. This discussion serves to review the basic pharmacological characteristics of ibuprofen, clinical presentations during an overdose, and management of ibuprofen toxicity.
An overdose of ibuprofen may be self-injurious, suicidal, or accidental. Young children may develop ibuprofen toxicity following exploratory ingestions.
Ibuprofen is one of the most commonly used and prescribed medications in the world. In the United States, 9% of overdoses in adolescents reported to poison control centers were from ibuprofen ingestion. In the United Kingdom, after the legalization of ibuprofen as an over-the-counter drug in 1984, there was a marked increase in ibuprofen overdose. According to the 2016 Annual Report of the American Association of Poison Control Centers’ National Poison Data System, analgesics constituted the most common drug class associated with adult exposures at 11.2% and the third most common amongst children at 9.2%. Among all analgesic overdoses, 29% had used ibuprofen exclusively or in combination with other analgesics, making ibuprofen the most common NSAID involved in overdose. In the United Kingdom, ibuprofen is the second most common substance (after acetaminophen) involved in telephone and TOXBASE inquiries to the National Poison Information Service from 2016 to 2017.
The therapeutic effects of ibuprofen are mediated by reversible binding to COX receptors (both COX-1 and COX-2) on prostaglandin synthase (also called cyclooxygenase, COX), thereby preventing arachidonic acid from binding to these sites. This prevents the conversion of arachidonic acid to the various prostaglandins that are instrumental in causing the 4 defining features of inflammation, namely redness (rubor), heat (calor), swelling (tumor), and pain (dolor). Prostaglandins also play a role in sensitizing pain-sensing nerve fibers, which explains the analgesic effect of ibuprofen and other NSAIDs. Ibuprofen also works on the thermoregulatory center of the hypothalamus to control fever.
Adverse effects associated with chronic ibuprofen use stem from the important roles prostaglandins and thromboxanes play in various organ systems, including the maintenance of gastric mucosal integrity and renal blood flow. Ibuprofen can, therefore, cause dyspeptic symptoms and gastrointestinal (GI) ulcers even at therapeutic doses. In the kidneys, this can lead to decreased renal perfusion in the afferent renal vessels especially in individuals with preexisting dehydration or renal impairment, thereby leading to decreased glomerular filtration rate (GFR).
Thromboxane A2, another substance produced by COX enzyme is vital for platelet aggregation and hence coagulation. The depletion of thromboxane A2 could, therefore, in theory, inhibit platelet aggregation and cause bleeding, especially in patients on anticoagulants or antiplatelets.
There have been reports of metabolic acidosis after an acute overdose of ibuprofen and other NSAIDs, which may be explained by the accumulation of acidic metabolites in the blood.
Ibuprofen is available as tablets with strengths ranging from 200 to 800 mg. It is also available as an elixir. It is well absorbed orally, with peak plasma concentrations reached in 1 to 2 hours. The onset of action after oral ingestion is 30 to 60 minutes for analgesia. The onset of antipyretic action varies with age ranging from less than an hour in adults to up to 3 hours in children. It is rapidly metabolized with a half-life of 1.8 to 2 hours. Ibuprofen is completely metabolized and eliminated in 24 hours. It is almost completely protein bound at 99%.
Symptoms from ibuprofen toxicity are unlikely at doses less than 100 mg/kg in children. Ingestion of more than 400 mg/kg in a child is associated with serious or life-threatening toxicity. No specific cutoff distinguishes asymptomatic from symptomatic overdose in adults.
Important points to be noted in history include the amount of ibuprofen ingested, the time of ingestion, and any co-ingestants. In children, caregivers should be specifically asked about acetaminophen ingestion, as it is commonly mistaken for ibuprofen. Most patients report no or mild symptoms following ibuprofen overdose. When symptoms do occur, onset typically occurs within 4 hours.
Ibuprofen toxicity can be discussed based on the organ system involved:
Gastrointestinal (GI) Toxicity
The COX-1 enzyme is found in the gastric mucosa and is instrumental in the production of prostaglandins that regulate blood flow and bicarbonate production in the stomach. Ibuprofen, being a nonselective inhibitor of COX, can disrupt the mucosal integrity of the gastric mucosa. Intramucosal hemorrhages occur within a few hours of ingestion in all NSAIDS, especially with acidic ones like ibuprofen. These may progress to erosions with continued use but are typically reversible. In susceptible individuals, they may progress to peptic ulcer. The severity of GI adverse effects can range from dyspepsia to life-threatening upper GI hemorrhage or viscus organ rupture. Symptoms include nausea, vomiting, dyspeptic symptoms, and abdominal pain.
Renal impairment has been described in individuals who had consumed therapeutic as well as supratherapeutic doses of ibuprofen. In children, there has been a report of a 2-year-old who had consumed 640 mg/kg of ibuprofen and developed acute renal failure with significant elevation of creatinine and microscopic hematuria with no proteins or casts in urine. Normalization of creatinine occurred after 72 hours. A prospective study of ibuprofen poisoning at Rocky Mountain Poison Control Center showed that 2 out of 63 cases had an elevation of creatinine after ingesting 4 and 4.5 g of ibuprofen respectively, suggesting that it is not a common occurrence. In most cases, renal impairment is reversible after supportive care and intravenous fluids. There has been a report of a patient requiring hemodialysis for months after developing renal failure following ingestion of massive amounts of ibuprofen, with the eventual recovery of renal function.
Acute ibuprofen overdose causing central nervous system (CNS) toxicity is not uncommon, particularly when the ingestion is massive at more than 400 mg/kg. In a prospective population-based ibuprofen overdose study, CNS depression was the second most clinical finding after gastrointestinal disturbances at 30%, but symptoms were mild. In another study, CNS depression was reported in 10% of subjects.
One case report describes a 50-year-old woman, who presented comatose after ingesting 40 to 60 tablets of ibuprofen 600 mg. The patient was unresponsive to verbal stimuli but responded to noxious stimuli. She was endotracheally intubated for airway protection. She developed renal failure and GI hemorrhage in the form of a guaiac positive stool test. After a day in the intensive care unit (ICU), she clinically improved and was extubated with no further complications. A similar case report of a male who reportedly ingested almost 20 grams of ibuprofen developed CNS depression, metabolic acidosis, thrombocytopenia, acute renal failure, and GI hemorrhage. His level of consciousness and other parameters improved with supportive management.
High anion gap metabolic acidosis is the most common abnormality that has been reported, which usually occurs after massive ingestions. This is believed to be due to the accumulation of acidic metabolites of ibuprofen, acute renal failure, and/or lactic acidosis from seizure activity. Apnea from respiratory depression can result in a concomitant respiratory acidosis.
Thrombocytopenia is common following ibuprofen overdose. Thrombocytopenia secondary to immune-mediated thrombocytopenia, thrombotic thrombocytopenic purpura, and hemolytic-uremic syndrome from ibuprofen ingestion have all been described. Prolonged prothrombin time may also occur. Pulmonary infiltrates with eosinophilia syndrome has been reported following ibuprofen overdose. Severe pancytopenia has also been reported.
Routine laboratory testing is unnecessary following an accidental overdose in asymptomatic patients provided that a history of acetaminophen overdose be excluded by history. When acetaminophen overdose cannot be excluded, a serum acetaminophen level should be obtained. Following large or self-injurious/suicidal overdose and in symptomatic patients, laboratory testing may include a complete blood count, blood gas analysis, and metabolic panel. Assessment for co-ingestants like ethanol, toxic alcohols, and aspirin may be appropriate depending on patent presentation. Serum ibuprofen concentrations are typically not readily available in the acute care setting but may be obtained from reference laboratories if confirmation of ibuprofen exposure is necessary.
Management of an ibuprofen toxicity patient is primarily supportive. Most patients have no symptoms or mild GI symptoms that respond to symptomatic management. Asymptomatic patients with normal vital signs and no acetaminophen poisoning may be observed for 4 to 6 hours for development of symptoms. Children who have consumed more than 400 mg/kg are at higher risk of ibuprofen toxicity and generally should be admitted to an acute care facility for further evaluation, while those who have ingested less than 100 mg/kg can be safely observed at home by their caretaker.
Gastrointestinal decontamination with activated charcoal may be used if there is a history of recent (within 2 hours) clinically significant ibuprofen overdose in adults and children with ingestion of more than 400 mg/kg. Patients with life-threatening manifestations like respiratory depression, hypotension, seizures, and metabolic acidosis should be aggressively treated. Therapeutic interventions may include airway stabilization, mechanical ventilation, benzodiazepines for seizure control, and intravenous fluids and vasopressors to correct hypotension. Monitor for life-threatening arrhythmias, which can occur secondary to electrolyte imbalances like hypokalemia, with serial ECGs. As ibuprofen is heavily protein bound, it cannot be removed by hemodialysis, although the latter can be used for associated conditions like hyperkalemia or refractory metabolic acidosis.
Managing ibuprofen overdose requires teamwork from healthcare professionals including the emergency physician, intensivist, medical toxicologist or poison control center, pharmacist, and nursing staff. The emergency physician is responsible for the following:
The management of ibuprofen toxicity should continue after the patient is admitted to an appropriate level of care. Patients should be admitted to an ICU level of care for respiratory depression, hypotension or shock, depressed mental status, severe metabolic acidosis, severe GI hemorrhage, life-threatening electrolyte imbalances or arrhythmias, or if the presumed clinical course of the patient is predicted to worsen based on the dose of ibuprofen consumed. Symptomatic but otherwise stable patients may be admitted to a general medical floor. Asymptomatic patients may be observed for 4 to 6 hours in the emergency department. (Level III)
The admitting team shall continue therapeutic interventions initiated in the emergency department in conjunction with consultants such as medical toxicologist or poison control center, nephrologist, and/or pharmacist. Consult with a mental health counselor or psychiatrist to assess the risk of self-harm and the potential need for psychiatric admission in intentional or self-injurious exposures.
|||Halford GM,Lordkipanidzé M,Watson SP, 50th anniversary of the discovery of ibuprofen: an interview with Dr Stewart Adams. Platelets. 2012 [PubMed PMID: 22098129]|
|||Konstan MW,VanDevanter DR,Sawicki GS,Pasta DJ,Foreman AJ,Neiman EA,Morgan WJ, Association of High-Dose Ibuprofen Use, Lung Function Decline, and Long-Term Survival in Children with Cystic Fibrosis. Annals of the American Thoracic Society. 2018 Apr [PubMed PMID: 29313709]|
|||Sheridan DC,Hendrickson RG,Lin AL,Fu R,Horowitz BZ, Adolescent Suicidal Ingestion: National Trends Over a Decade. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 2017 Feb [PubMed PMID: 27889404]|
|||Perry SJ,Streete PJ,Volans GN, Ibuprofen overdose: the first two years of over-the-counter sales. Human toxicology. 1987 Mar [PubMed PMID: 3557476]|
|||Gummin DD,Mowry JB,Spyker DA,Brooks DE,Fraser MO,Banner W, 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report. Clinical toxicology (Philadelphia, Pa.). 2017 Dec [PubMed PMID: 29185815]|
|||Davies NM, Clinical pharmacokinetics of ibuprofen. The first 30 years. Clinical pharmacokinetics. 1998 Feb [PubMed PMID: 9515184]|
|||Kauffman RE,Nelson MV, Effect of age on ibuprofen pharmacokinetics and antipyretic response. The Journal of pediatrics. 1992 Dec [PubMed PMID: 1447669]|
|||Sullivan JE,Farrar HC, Fever and antipyretic use in children. Pediatrics. 2011 Mar [PubMed PMID: 21357332]|
|||Antal EJ,Wright CE 3rd,Brown BL,Albert KS,Aman LC,Levin NW, The influence of hemodialysis on the pharmacokinetics of ibuprofen and its major metabolites. Journal of clinical pharmacology. 1986 Mar [PubMed PMID: 3958223]|
|||Wanwimolruk S,Brooks PM,Birkett DJ, Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients. British journal of clinical pharmacology. 1983 Jan [PubMed PMID: 6849750]|
|||Hall AH,Smolinske SC,Conrad FL,Wruk KM,Kulig KW,Dwelle TL,Rumack BH, Ibuprofen overdose: 126 cases. Annals of emergency medicine. 1986 Nov [PubMed PMID: 3777588]|
|||Volans G,Monaghan J,Colbridge M, Ibuprofen overdose. International journal of clinical practice. Supplement. 2003 Apr [PubMed PMID: 12723749]|
|||Kimmey MB,Silverstein FE,Saunders DR,Chapman RC, Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine. Digestive diseases and sciences. 1987 Aug [PubMed PMID: 3301232]|
|||Marciniak KE,Thomas IH,Brogan TV,Roberts JS,Czaja A,Mazor SS, Massive ibuprofen overdose requiring extracorporeal membrane oxygenation for cardiovascular support. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2007 Mar [PubMed PMID: 17273120]|
|||Lee CY,Finkler A, Acute intoxication due to ibuprofen overdose. Archives of pathology [PubMed PMID: 3755329]|
|||Clarke SF,Arepalli N,Armstrong C,Dargan PI, Duodenal perforation after ibuprofen overdose. Journal of toxicology. Clinical toxicology. 2004 [PubMed PMID: 15641644]|
|||Whelton A,Stout RL,Spilman PS,Klassen DK, Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison. Annals of internal medicine. 1990 Apr 15 [PubMed PMID: 2183665]|
|||Murray MD,Brater DC, Adverse effects of nonsteroidal anti-inflammatory drugs on renal function. Annals of internal medicine. 1990 Apr 15 [PubMed PMID: 2327675]|
|||Kim J,Gazarian M,Verjee Z,Johnson D, Acute renal insufficiency in ibuprofen overdose. Pediatric emergency care. 1995 Apr [PubMed PMID: 7596869]|
|||Hall AH,Smolinske SC,Stover B,Conrad FL,Rumack BH, Ibuprofen overdose in adults. Journal of toxicology. Clinical toxicology. 1992 [PubMed PMID: 1542147]|
|||Court H,Volans GN, Poisoning after overdose with non-steroidal anti-inflammatory drugs. Adverse drug reactions and acute poisoning reviews. 1984 Spring [PubMed PMID: 6541425]|
|||Mattana J,Perinbasekar S,Brod-Miller C, Near-fatal but reversible acute renal failure after massive ibuprofen ingestion. The American journal of the medical sciences. 1997 Feb [PubMed PMID: 9030680]|
|||McElwee NE,Veltri JC,Bradford DC,Rollins DE, A prospective, population-based study of acute ibuprofen overdose: complications are rare and routine serum levels not warranted. Annals of emergency medicine. 1990 Jun [PubMed PMID: 2188537]|
|||Chelluri L,Jastremski MS, Coma caused by ibuprofen overdose. Critical care medicine. 1986 Dec [PubMed PMID: 3780253]|
|||Oker EE,Hermann L,Baum CR,Fentzke KM,Sigg T,Leikin JB, Serious toxicity in a young child due to ibuprofen. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2000 Jul [PubMed PMID: 10917334]|
|||Easley RB,Altemeier WA 3rd, Central nervous system manifestations of an ibuprofen overdose reversed by naloxone. Pediatric emergency care. 2000 Feb [PubMed PMID: 10698143]|
|||Holubek W,Stolbach A,Nurok S,Lopez O,Wetter A,Nelson L, A report of two deaths from massive ibuprofen ingestion. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2007 Jun [PubMed PMID: 18072160]|
|||Zuckerman GB,Uy CC, Shock, metabolic acidosis, and coma following ibuprofen overdose in a child. The Annals of pharmacotherapy. 1995 Sep [PubMed PMID: 8547735]|
|||Page CB,Wilson PA,Foy A,Downes MA,Whyte IM,Isbister GK, Life-threatening hypokalaemia associated with ibuprofen-induced renal tubular acidosis. The Medical journal of Australia. 2011 Jun 6 [PubMed PMID: 21644884]|
|||Levine M,Khurana A,Ruha AM, Polyuria, acidosis, and coma following massive ibuprofen ingestion. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2010 Sep [PubMed PMID: 20419362]|
|||Jain S, Ibuprofen-induced thrombocytopenia. The British journal of clinical practice. 1994 Jan-Feb [PubMed PMID: 8179987]|
|||Seifert SA,Bronstein AC,McGuire T, Massive ibuprofen ingestion with survival. Journal of toxicology. Clinical toxicology. 2000 [PubMed PMID: 10696926]|
|||Meyer T,Herrmann C,Wiegand V,Mathias B,Kiefel V,Mueller-Eckhardt C, Immune thrombocytopenia associated with hemorrhagic diathesis due to ibuprofen administration. The Clinical investigator. 1993 May [PubMed PMID: 8508012]|
|||Benmoussa J,Chevenon M,Nandi M,Forlenza TJ,Nfonoyim J, Ibuprofen-induced thrombotic thrombocytopenic purpura. The American journal of emergency medicine. 2016 May [PubMed PMID: 26643158]|
|||Schoenmaker NJ,Weening JJ,Krediet RT, Ibuprofen-induced HUS. Clinical nephrology. 2007 Sep [PubMed PMID: 17915621]|
|||Soos A, [Thrombocytopenic purpura caused by ibuprofen]. Ugeskrift for laeger. 1979 Oct 15 [PubMed PMID: 574324]|
|||Catizone L,Santoro A,Scialfa G,Cagnoli L,Fabbri L, [Thrombotic thrombocytopenic purpura due to administration of Ibuprofen]. Minerva nefrologica. 1974 Nov-Dec [PubMed PMID: 4477894]|
|||Vogts N,Young S, Pulmonary infiltrates with eosinophilia syndrome in ibuprofen overdose. The New Zealand medical journal. 2012 Aug 24 [PubMed PMID: 22932657]|
|||Lindblad R,R�djer S, A case of severe pancytopenia caused by ibuprofen. Journal of internal medicine. 1991 Mar [PubMed PMID: 2007846]|
|||Lapatto-Reiniluoto O,Kivist� KT,Neuvonen PJ, Effect of activated charcoal alone or given after gastric lavage in reducing the absorption of diazepam, ibuprofen and citalopram. British journal of clinical pharmacology. 1999 Aug [PubMed PMID: 10417490]|